The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus

Journal of Chronic Diseases

Volumn 27, Issue 7-8, 1974, Pages 387-404

  Kaplan, Moreson H ^a,b,c   Feinstein, Alvan R ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYZER; CARDIOVASCULAR SYSTEM; CAUSE OF DEATH; CLASSIFICATION; DIABETES MELLITUS; DISEASE CLASSIFICATION; EPIDEMIOLOGY; FOLLOW UP; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; STATISTICS; THERAPY;

ADULT; AGE FACTORS; AGED; DIABETES MELLITUS; FOLLOW-UP STUDIES; HUMAN; MALE; METHODS; MIDDLE AGE; PROGNOSIS; STATISTICS; VASCULAR DISEASES;

EID: 0016205557     PISSN: 00219681     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9681(74)90017-4     Document Type: Article

References (14)

1. Clinical epidemiology. III. The clinical design of statistics in therapy
2. A critique of methods in reported studies of longterm vascular complications in patients with diabetes mellitus
3. Clinical biostatistics. XI. Sources of ‘chronology bias’ in cohort statistics
4. Clinical biostatistics. VII. The rancid sample, the tilted target, and the medical poll-bearer
5. The pre-therapeutic classification of co-morbidity in chronic disease
6. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. Part I: Design, methods and baseline characteristics. Part II: Mortality results
7. The epidemiology of cancer therapy. II. The clinical course: data, decisions, and temporal demarcations
8. Calculation of survival rates for cancer
9. Maximum utilization of the life table method in analyzing survival
10. Clinical biostatistics. XVII. Synchronous partition and bivariate evaluation in predictive stratification
11. The effect of treatment of moderate hyperglycemia on the incidence of arterial disease
12. The University Group Diabetes Program. A further statistical analysis of the mortality findings
13. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes III Clinical implications of UGDP results